Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 128014, 5 pages
http://dx.doi.org/10.1155/2014/128014
Research Article

Decreased Plasma Nesfatin-1 Level Is Related to the Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus

1Department of Endocrinology, Central People’s Hospital of Tengzhou City, Tengzhou, Shandong 277500, China
2Department of Medicine, Maternal and Child Care Service Centre of Tengzhou City, Tengzhou, Shandong 277500, China
3Department of Endocrinology, Qianfoshan Hospital of Shandong University, Jinan, Shandong 250000, China

Received 27 March 2014; Accepted 21 May 2014; Published 4 June 2014

Academic Editor: Hiroshi Okamoto

Copyright © 2014 Fupeng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Feely and T. E. Isles, “Screening for thyroid dysfunction in diabetics,” The British Medical Journal, vol. 1, no. 6179, p. 1678, 1979. View at Google Scholar · View at Scopus
  2. R. S. Gray, D. Q. Borsey, J. Seth, R. Herd, N. S. Brown, and B. F. Clarke, “Prevalence of subclinical thyroid failure in insulin-dependent diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 50, no. 6, pp. 1034–1037, 1980. View at Google Scholar · View at Scopus
  3. G. Gambelunghe, F. Forini, S. Laureti et al., “Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies,” Clinical Endocrinology, vol. 52, no. 5, pp. 565–573, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Oh-I, H. Shimizu, T. Satoh et al., “Identification of nesfatin-1 as a satiety molecule in the hypothalamus,” Nature, vol. 443, no. 7112, pp. 709–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Shimizu, S. Oh-I, K. Hashimoto et al., “Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism,” Endocrinology, vol. 150, no. 2, pp. 662–671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Su, J. Zhang, Y. Tang, F. Bi, and J.-N. Liu, “The novel function of nesfatin-1: anti-hyperglycemia,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 1039–1042, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nakata, K. Manaka, S. Yamamoto, M. Mori, and T. Yada, “Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca2+ influx through L-type channels in mouse islet β-cells,” Endocrine Journal, vol. 58, no. 4, pp. 305–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. C. Brailoiu, S. L. Dun, E. Brailoiu et al., “Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain,” Endocrinology, vol. 148, no. 10, pp. 5088–5094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Orban, S. R. Bornstein, and G. P. Chrousos, “The interaction between leptin and the hypothalamic-pituitary-thyroid axis,” Hormone and Metabolic Research, vol. 30, no. 5, pp. 231–235, 1998. View at Google Scholar · View at Scopus
  10. C. J. Price, T. D. Hoyda, W. K. Samson, and A. V. Ferguson, “Nesfatin-1 influences the excitability of paraventricular nucleus neurones,” Journal of Neuroendocrinology, vol. 20, no. 2, pp. 245–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Sawicka, A. Bossowski, M. Szalecki et al., “Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases,” Journal of Pediatric Endocrinology and Metabolism, vol. 23, no. 4, pp. 345–354, 2010. View at Google Scholar · View at Scopus
  12. Y. Taché and A. Stengel, “Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight,” Current Gastroenterology Reports, vol. 11, no. 6, pp. 448–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A.-R. M. Radaideh, M. K. Nusier, F. L. Amari et al., “Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan,” Saudi Medical Journal, vol. 25, no. 8, pp. 1046–1050, 2004. View at Google Scholar · View at Scopus
  14. J. Sowiński, L. Czupryniak, A. Milewicz et al., “Recommendations of the Polish Society of Endocrinology and Polish Diabetes Association for the management of thyroid dysfunction in type 1 and type 2 diabetes,” Endokrynologia Polska, vol. 64, no. 1, pp. 73–77, 2013. View at Google Scholar · View at Scopus
  15. L. H. Duntas, J. Orgiazzi, and G. Brabant, “The interface between thyroid and diabetes mellitus,” Clinical Endocrinology, vol. 75, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Varela, N. Martínez-Sánchez, R. Gallego et al., “Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism,” The Journal of Pathology, vol. 227, no. 2, pp. 209–222, 2012. View at Publisher · View at Google Scholar
  17. N. Musi, M. F. Hirshman, J. Nygren et al., “Metformin increases AMP-activated protein-kinase activity in skeletal muscle of subjects with type 2 diabetes,” Diabetes, vol. 51, no. 7, pp. 2074–2081, 2002. View at Google Scholar · View at Scopus
  18. X. Wu, H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia, and B. J. Goldstein, “Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes,” Diabetes, vol. 52, no. 6, pp. 1355–1363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Gonzalez, B. K. Reingold, X. Gao, M. P. Gaidhu, R. G. Tsushima, and S. Unniappan, “Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells,” Journal of Endocrinology, vol. 208, no. 3, pp. R9–R16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Riva, M. D. Nitert, U. Voss et al., “Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects,” Cell and Tissue Research, vol. 346, no. 3, pp. 393–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Yang, Z. Zhang, C. Wang et al., “Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance,” Diabetes, vol. 61, no. 8, pp. 1959–1968, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Kohno, M. Nakata, Y. Maejima et al., “Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding,” Endocrinology, vol. 149, no. 3, pp. 1295–1301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Q.-C. Li, H.-Y. Wang, X. Chen, H.-Z. Guan, and Z.-Y. Jiang, “Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans,” Regulatory Peptides, vol. 159, no. 1–3, pp. 72–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhang, L. Li, M. Yang, H. Liu, G. Boden, and G. Yang, “Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 2, pp. 91–95, 2012. View at Publisher · View at Google Scholar · View at Scopus